*雜質(zhì) 提供圖譜?? 產(chǎn)品介紹：
所有雜質(zhì)均隨貨提供CoA證書(shū)，HPLC，MS，HNMR圖譜等。
雜質(zhì)種類(lèi)齊全，并可提供雜質(zhì)定制合成服務(wù)，歡迎提供所需結(jié)構(gòu)式詳詢(xún)。
*雜質(zhì) 提供圖譜??? 產(chǎn)品信息請(qǐng)：
任： ； ；
國(guó)產(chǎn)進(jìn)口品牌皆有銷(xiāo)售，部分雜質(zhì)*備有庫(kù)存，可快速發(fā)貨，并可定制合成。
?? 雜質(zhì)詳情：
中文名稱(chēng) | 英文名稱(chēng) |
*標(biāo)準(zhǔn)品 | Linagliptin |
*雜質(zhì)1 | 2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide |
*雜質(zhì)2 | (R)-7-(but-2-yn-1-yl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
*雜質(zhì)3 | N-Phthalimide-linagliptin |
*雜質(zhì)4 | N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide |
*雜質(zhì)5 | (R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid |
*雜質(zhì)6 | 8-((R)-3-aminopiperidin-1-yl)-7-((R)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione compound with 8-((R)-3-aminopiperidin-1-yl)-7-((S)-buta-1,2-dien-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (1:1) |
*雜質(zhì)7 | Linagliptin Diene Impurity |
*雜質(zhì)8 | Linagliptin Acetamide |
*雜質(zhì)9 | (R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
*雜質(zhì)10 | (R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
*雜質(zhì)11 | 8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
*雜質(zhì)12 | (R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
*雜質(zhì)13 | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
*雜質(zhì)14 | (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione |
*雜質(zhì)15 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide |
*雜質(zhì)16 | (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
*雜質(zhì)17 | (S)-Linagliptin |
*雜質(zhì)18 | N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
*雜質(zhì)19 | (R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
*雜質(zhì)20 | (R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide |
*雜質(zhì)21 | (R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
*雜質(zhì)22 | (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
*雜質(zhì)23 | (S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate |
*雜質(zhì)24 | (R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione |
*雜質(zhì)25 | (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide |
鄭州艾利蒙生物科技有限公司除國(guó)產(chǎn)雜質(zhì)對(duì)照品外，代理有加拿大TLC雜質(zhì)對(duì)照品，TRC雜質(zhì)對(duì)照品，MC雜質(zhì)對(duì)照品，英國(guó)NIBSC標(biāo)準(zhǔn)品，美國(guó)CIL同位素標(biāo)準(zhǔn)品，NIST標(biāo)準(zhǔn)物質(zhì)，歐洲標(biāo)準(zhǔn)局IRMM標(biāo)準(zhǔn)物質(zhì)等，原廠(chǎng)訂貨，質(zhì)量保證。
?? 美國(guó)劍橋CIL標(biāo)準(zhǔn)品部分產(chǎn)品列表：
SNLM-3984-PK | TIN-112 METAL (112Sn) |
EC-1415-1.2 | 2,3,3',5,5'-PENTACB (PCB-111) (13C12, 99%) 40+/-2 UG/ML IN NONANE |
DLM-9126-0.005 | VITAMIN E (ALPHA-TOCOPHEROL) (5-METHYL-D3;7-METHYL-D3,98%) |
DLM-294-25 | NITROBENZENE-D5 (D, 99%) |
T-030 | TRAZODONE: HCL UNLABELED 1 MG/ML AS FREE BASE IN METHANOL |
CLM-1160-0.5 | ACETIC ANHYDRIDE (2,2'-13C2, 99%) |
EDF-5409 | BROMODIOXIN/FURAN SYRINGE SPIKE (13C12, 99%) |
CLM-8824-PK | IODOACETIC ACID (13C2, 99%) |
M-085 | MORPHINE (D6, 98%) 100 UG/ML IN METHANOL |
CLM-2436-0 | ACETAMINOPHEN (CARBONYL-13C, 99%) |
EDF-2681 | SUPPLEMENTAL INTERNAL STANDARD SOLUTION (13C12, 99%) |
EDF-4095 | MODIFIED METHOD 8280 CALIBRATION SOLUTIONS |
NLM-177-PK | AMMONIUM ACETATE (15N, 98%+) |
PCB-178 | 2,2',3,3',5,5',6-HEPTACB UNLABELED 35 UG/ML IN ISOOCTANE |
EC-5372-1/10X-10 | EN-1948-4 WHO PCB EXTRACTION SPIKE (13C12, 99%) 10 NG/ML IN NONANE |
DLM-1063-10 | POTASSIUM DIDEUTERIUM PHOSPHATE (D2, 98%) |
DLM-170-0.05 | DIETHYLSTILBESTROL (CIS/TRANS MIX) (RING-3,3',5,5'-DIETHYL-1,1,1',1'-D8, 98%) |
CLM-1604-0 | DIFLUOROMETHANE (13C, 99%) |
ED-1440 | 2,3,7,8-TETRABROMODIBENZO-P-DIOXIN (13C12, 99%) 5 UG/ML IN NONANE |
CLM-2093-MPT-PK | ALPHA-KETOISOCAPROIC ACID, SODIUM SALT (1-13C, 99%) MICROBIOLOGICAL/PYROGEN TESTED |
CLM-1189-PK | D-MANNITOL (1-13C, 98%) |
DLM-91 | 2 mM SUCROSE + 0.5 mM DSS + 2 mM NAN3 IN 90% H2O/10% D2O H2O:D2O=V/V |
CLM-3706-MPT-PK | SODIUM D-3-HYDROXYBUTYRATE (2,4-13C2, 99%) MICROBIOLOGICAL/PYROGEN TESTED |
ULM-4559-1.2 | P-N-NONYLPHENOL UNLABELED 100 UG/ML IN NONANE |
DLM-45-PK | SODIUM DEUTEROXIDE (D, 99.5%) 40% IN D2O |
??
環(huán)保在線(xiàn)